Live tape
Top 8, mentions 7d7,501META2,263 mentions▲ +0.06GOOGL1,504 mentions▲ +0.02NVDA796 mentions▲ +0.09MUSE665 mentions▲ +0.07MSFT602 mentions▲ +0.05SPY567 mentions▲ +0.05QQQ555 mentions▲ +0.08TSLA549 mentions▲ +0.06

Equity · Healthcare

SGRY

Surgery Partners, Inc. · NasdaqGS

$16 −5.88% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart
Our own end-of-day closes 13 sessions
$18 $15 30 Jun 17 Jul

The line runs $16.79 on 30 June through $16 on 17 July, on a scale from $15 to $18. Days the market did not trade hold the previous close, flat.

The chart above plots the price of SGRY over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 13 sessions over that window: $16.79 on 30 June 2026 through $16 on 17 July 2026.

Market cap $2.1B
52-week range $11.49 – $23.81
Avg volume 296.5K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 17, 2026

SGRY insider trades

SEC Form 4 · last 90 days · newest reported trade 18 Aug 2026
Open-market buys 1
Open-market sells 0
Net bought $305K
Non-trade filings 0
Date Insider Type Shares Value
18 Aug 2026 DeLuca Teresa Director Buy 21,250 $305K

SGRY reported financials

SEC EDGAR XBRL

SGRY reported revenue of $3.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$77.9M.

Figure Reported Period
Revenue $3.3B 31 Dec 2025 fiscal year
Net income −$77.9M 31 Dec 2025 fiscal year
Diluted EPS −$0.61 31 Dec 2025 fiscal year
Total assets $8.0B 30 Jun 2026 at period end
Total equity $1.7B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

SGRY earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.12 —
31 Mar 2026 Q1 2026 $-0.28 —
31 Dec 2025 FY 2025 $-0.61 —
30 Sep 2025 Q3 2025 $-0.18 —
30 Jun 2025 Q2 2025 $-0.02 —
31 Mar 2025 Q1 2025 $-0.30 —
31 Dec 2024 FY 2024 $-1.33 —
30 Sep 2024 Q3 2024 $-0.25 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

SGRY institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a SGRY position for the quarter ended 30 Jun 2026 — a combined $39.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Oaktree Capital Management New position 862,588 $14.5M
Man Group Trimmed −26.3% shares 697,552 $11.7M
Citadel Advisors Trimmed −27.5% shares 291,280 $4.9M
Tudor Investment Corp Trimmed −43.0% shares 153,926 $2.6M
Renaissance Technologies New position 130,100 $2.2M
Marshall Wace Added +643.5% shares 95,362 $1.6M
Balyasny Asset Management New position 64,377 $1.1M
AQR Capital Management Added +286.1% shares 46,155 $775K

Source: SEC EDGAR 13F filings

SGRY fails-to-deliver

SEC CNS data

On 26 Aug 2026, 883 shares of SGRY failed to deliver (about $12K).

Settlement date Shares failed Notional % of shares out
26 Aug 2026 883 $12K 0.001%
24 Aug 2026 1,877 $27K 0.001%

Source: SEC fails-to-deliver (CNS) data